Carbon Mirror platform which is a computer simulation to understand drug-bacteria interactions which hopes to improve a person's response to treatments
BioCorteX has raised €4.6M across 1 funding round from 2 investors, most recently a Seed round in Mar 2023. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-31 | Seed | €4.6M |
| Hoxton Ventures,Sofinnova Partners |
| View deal → |
